江苏省药物研究所有限公司，始建于1962 年7 月，隶属于江苏省卫生厅、江苏省科技厅，2006年12月，整体合并进入南京工业大学。是专门从事新药创制与开发研究的专业科研机构，江苏省新药临床前研究基地，国家新药临床前安全评价中心，国家高新技术企业。江苏省药物研究所一直致力于新药研制开发，获国家新药证书168份。新药成果转化率达98%以上。累计为相关合作企业创造产值256亿元。

典型案例

●注射用紫杉醇脂质体

●注射用两性霉素B脂质体 

●依托泊苷软胶囊（江苏恒瑞）

Jiangsu Provincial Institute of Materia Medica Co.Ltd, was founded in July 1962, was affiliated to the Jiangsu Provincial Department of Health and the Jiangsu Provincial Science and Technology Department. In December 2006, the company merged into Nanjing Technology University. As a professional scientific research institution specializing in the drug discovery and drug development, the company is a Center for Preclinical Study for New Drugs of Jiangsu Province, a National Preclinical Safety Evaluation Center for New Drugs, and a National High-tech Enterprise.

Jiangsu Provincial Institute of Materia Medica Co.Ltd has been committed to the new drug discovery and development, and has obtained 168 national new drug certificates. The conversion rate of new drug achievements has reached more than 98%. The total output value of relevant cooperative enterprises has been 25.6 billion yuan.

Examples Insights

●Paclitaxel liposomes

●Amphotericin B liposomes for injection

●Etoposide Softgels（Jiangsu Hengrui Pharmaceutical Co., Ltd.）